Herpes Zoster Resources and References

Resources

• Prevention of Herpes Zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
  MMWR (15 May 2008) reports first statement by ACIP on use of live attenuated vaccine for the prevention of herpes zoster
• CDC. Updated recommendations for use of VariZIG – United States, 2013. MMWR. 2013;62(28):574-6.

Disease-related Resources

• Slide set: Overview of VZV Disease & Vaccination for Healthcare Professionals [57 slides]
• Shingles Overview
  Information from the American Academy of Family Physicians
• AgePage
  Shingles information from the National Institute on Aging which includes a printable brochure on shingles
• Resources on Shingles from NINDS
  Information from the National Institute of Neurological Disorders and Stroke
• Shingles Interactive Tutorial
  A tutorial from the Patient Education Institute, also available in Spanish

Vaccine-related Resources

• Vaccination References and Resources
  MMWRs on Varicella, Pink Book’s chapter on Varicella, Travelers Health: Yellow Book…
• Zostavax Questions and Answers
  Questions and answers about the Zostavax® vaccine from the U.S. Food and Drug Administration
• Provider Education
  CDC herpes zoster podcast, courses, broadcasts, webcasts, and slide sets
• Materials for Patients
  Printable fact sheets and VISs
• Media Resources
  CDC vaccine message and press release
• Podcast: There’s a Vaccine for Shingles?!
  Posted Jul 2009

 Top of Page

References

Journal Articles

• Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Diez-Domingo J, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med. 2016:375(11), 1019-32.
• Kawai, K., Yawn, B. P., Wollan, P., & Harpaz, R. (2016). Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study. Clin Infect Dis, 63(2), 221-226.
• Tseng, H. F., Harpaz, R., Luo, Y., Hales, C. M., Sy, L. S., Tartof, S. Y., Bialek, S., Hechter, R. C., & Jacobsen, S. J. (2016). Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged >/=60 Years. J Infect Dis, 213(12), 1872-1875.
• Cohen, J. I. (2013). Herpes zoster. N Engl J Med, 369(18), 1766-1767.
• Hales, C. M., Harpaz, R., Joesoef, M. R., & Bialek, S. R. (2013). Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann Intern Med, 159(11), 739-745.
• Lu, P. J., Euler, G. L., & Harpaz, R. (2011). Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008. Am J Prev Med, 40(2), e1-6.
• Tseng, H. F., Smith, N., Harpaz, R., Bialek, S. R., Sy, L. S., & Jacobsen, S. J. (2011). Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. Jama, 305(2), 160-6.
• Gershon, A. A., Gershon, M. D., Breuer, J., Levin, M. J., Oaklander, A. L., & Griffiths, P. D. (2010). Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol, 48 Suppl 1, S2-7.
• Levin, M. J., Gershon, A. A., Dworkin, R. H., Brisson, M., & Stanberry, L. (2010). Prevention strategies for herpes zoster and post-herpetic neuralgia. J Clin Virol, 48 Suppl 1, S14-19.
• Amlie-Lefond, C., & Jubelt, B. (2009). Neurologic manifestations of varicella zoster virus infections. Curr Neurol Neurosci Rep, 9(6), 430-434.
• Dworkin, R. H., Barbano, R. L., Tyring, S. K., Betts, R. F., McDermott, M. P., Pennella-Vaughan, J., Bennett, G. J., Berber, E., Gnann, J. W., Irvine, C., Kamp, C., Kieburtz, K., Max, M. B., & Schmader, K. E. (2009). A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain, 142(3), 209-217.
• Sampathkumar, P., Drage, L. A., & Martin, D. P. (2009). Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc, 84(3), 274-280.
• Sanjay, S., Chan, E. W., Gopal, L., Hegde, S. R., & Chang, B. C. (2009). Complete unilateral ophthalmoplegia in herpes zoster ophthalmicus. J Neuroophthalmol, 29(4), 325-337.
• Kimberlin, D. W., & Whitley, R. J. (2007). Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med, 356(13), 1338-1343.
• Marin, M., Guris, D., Chaves, S. S., Schmid, S., Seward, J. F., Advisory Committee on Immunization Practices, C. f. D. C., & Prevention. (2007). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep, 56(RR-4), 1-40.
• Nagel, M. A., & Gilden, D. H. (2007). The protean neurologic manifestations of varicella-zoster virus infection. Cleve Clin J Med, 74(7), 489-494, 496, 498-489 passim.
• Schmader, K. (2007). Herpes zoster and postherpetic neuralgia in older adults. Clin Geriatr Med, 23(3), 615-632, vii-viii.
• Sugisaki, K., & Yoshida, H. (2007). Varicella zoster virus meningoencephalitis accompanied by sporadic skin lesions in an older immunocompetent adult. J Infect Chemother, 13(4), 270-272.
• Yawn, B. P., Saddier, P., Wollan, P. C., St Sauver, J. L., Kurland, M. J., & Sy, L. S. (2007). A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc, 82(11), 1341-1349.
• Gilden, D. H., Cohrs, R. J., & Mahalingam, R. (2005). VZV vasculopathy and postherpetic neuralgia: progress and perspective on antiviral therapy. Neurology, 64(1), 21-25.
• Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005:352(22), 2271-84.
• Thomas, S. L., & Hall, A. J. (2004). What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis, 4(1), 26-33.
• Gnann, J. W., Jr., & Whitley, R. J. (2002). Clinical practice. Herpes zoster. N Engl J Med, 347(5), 340-346.

 Top of Page